Ensign Peak Advisors
CME icon

Ensign Peak Advisors’s CME Group CME Stock Holding History

Ensign Peak Advisors’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136M Sell
613,983
-29,370
-5% -$8.12M 0.22% 94
2026
Q1 		$190M Buy
643,353
+27,425
+4% +$8.15M 0.35% 53
2025
Q4 		$168M Sell
615,928
-15,417
-2% -$4.19M 0.3% 69
2025
Q3 		$171M Sell
631,345
-43,862
-6% -$11.9M 0.28% 70
2025
Q2 		$186M Buy
675,207
+57,317
+9% +$15.6M 0.32% 67
2025
Q1 		$164M Buy
617,890
+10,711
+2% +$2.64M 0.31% 69
2024
Q4 		$141M Sell
607,179
-37,661
-6% -$8.66M 0.25% 76
2024
Q3 		$142M Sell
644,840
-1,170
-0.2% -$242K 0.25% 80
2024
Q2 		$127M Sell
646,010
-76,300
-11% -$15.8M 0.23% 85
2024
Q1 		$156M Sell
722,310
-595,243
-45% -$125M 0.28% 69
2023
Q4 		$277M Sell
1,317,553
-496,988
-27% -$106M 0.55% 40
2023
Q3 		$363M Buy
1,814,541
+29,143
+2% +$5.79M 0.78% 24
2023
Q2 		$331M Buy
1,785,398
+51,752
+3% +$9.56M 0.67% 30
2023
Q1 		$332M Buy
1,733,646
+170,433
+11% +$30.8M 0.72% 30
2022
Q4 		$263M Sell
1,563,213
-76,535
-5% -$13.3M 0.59% 40
2022
Q3 		$290M Buy
1,639,748
+244,472
+18% +$48.3M 0.72% 33
2022
Q2 		$286M Buy
1,395,276
+205,733
+17% +$43.6M 0.68% 34
2022
Q1 		$283M Buy
1,189,543
+320,934
+37% +$75.4M 0.58% 41
2021
Q4 		$198M Sell
868,609
-4,332
-0.5% -$953K 0.38% 66
2021
Q3 		$169M Buy
872,941
+27,761
+3% +$5.62M 0.35% 76
2021
Q2 		$180M Sell
845,180
-62,393
-7% -$13.2M 0.36% 74
2021
Q1 		$185M Buy
907,573
+39,972
+5% +$7.87M 0.4% 66
2020
Q4 		$158M Buy
867,601
+48,243
+6% +$8.2M 0.36% 67
2020
Q3 		$137M Buy
819,358
+18,464
+2% +$3.11M 0.35% 65
2020
Q2 		$130M Sell
800,894
-728,839
-48% -$131M 0.35% 65
2020
Q1 		$265M Buy
1,529,733
+187,975
+14% +$37.4M 0.89% 20
2019
Q4 		$269M Buy
+1,341,758
New +$275M 0.71% 34

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Ensign Peak Advisors's CME Position: Q2 2026 in Review

Ensign Peak Advisors reduced its CME Group (CME) stake by 4.6% in Q2 2026, selling an estimated $8.12M and leaving 613,983 shares worth $136M. The position accounts for 0.22% of the portfolio, ranked #94.

Ensign Peak Advisors first reported a position in CME in Q4 2019 and has held it in 27 quarters since. The position peaked at $363M in Q3 2023. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Ensign Peak Advisors held 613,983 shares of CME Group worth $136M as of Q2 2026.
  • Ensign Peak Advisors sold 29,370 CME Group shares in Q2 2026, an estimated $8.12M.
  • CME Group made up 0.22% of Ensign Peak Advisors's portfolio in Q2 2026, its #94 holding.
  • Ensign Peak Advisors first reported a position in CME Group in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's CME Group position peaked at $363M in Q3 2023.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.